SG Americas Securities’s DexCom DXCM Stock Holding History

SG Americas Securities’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-68,900	Closed	-$818K	–	3426
2026 Q1	$818K	Sell	68,900 -2,000	-3%	-$139K	﹤0.01%	1893
2025 Q4	$1.06M	Hold	70,900	–	–	﹤0.01%	1960
2025 Q3	$702K	Buy	70,900 +58,500	+472%	+$4.63M	﹤0.01%	1801
2025 Q2	$43K	Sell	12,400 -15,600	-56%	-$1.22M	﹤0.01%	2777
2025 Q1	$182K	Sell	28,000 -17,000	-38%	-$1.39M	﹤0.01%	2597
2024 Q4	$72K	Buy	45,000 +17,000	+61%	+$1.26M	﹤0.01%	2831
2024 Q3	$116K	Buy	+28,000	New	+$2.3M	﹤0.01%	2944
2024 Q2	–	Sell	-25,000	Closed	-$25K	–	2960
2024 Q1	$25K	Hold	25,000	–	–	﹤0.01%	2846
2023 Q4	$108K	Hold	25,000	–	–	﹤0.01%	2706
2023 Q3	$365K	Buy	+25,000	New	+$2.82M	﹤0.01%	1967
2023 Q1	–	Sell	-28,500	Closed	-$15K	–	3326
2022 Q4	$15K	Hold	28,500	–	–	﹤0.01%	2955
2022 Q3	$221K	Buy	28,500 +9,700	+52%	+$822K	﹤0.01%	2236
2022 Q2	$309K	Buy	+18,800	New	+$1.72M	﹤0.01%	2364
2020 Q1	–	Sell	-120,000	Closed	-$159K	–	3494
2019 Q4	$159K	Buy	+120,000	New	+$5.69M	﹤0.01%	2648

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SG Americas Securities's DXCM Position: Q2 2026 in Review

SG Americas Securities reduced its DexCom (DXCM) stake by 60% in Q2 2026, selling an estimated $83M and leaving 818,912 shares worth $55.2M. The position accounts for 0.03% of the portfolio, ranked #333.

SG Americas Securities first reported a position in DXCM in Q3 2013 and has held it in 43 quarters since. The position peaked at $130M in Q1 2026. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

SG Americas Securities held 818,912 shares of DexCom worth $55.2M as of Q2 2026.
SG Americas Securities sold 1,246,365 DexCom shares in Q2 2026, an estimated $83M.
DexCom made up 0.03% of SG Americas Securities's portfolio in Q2 2026, its #333 holding.
SG Americas Securities first reported a position in DexCom in Q3 2013 and has held it in 43 quarters since.
SG Americas Securities's DexCom position peaked at $130M in Q1 2026.
974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.